EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens

Fatemeh Fazel, Ayumi Matsuyama-Kato iD, Mohammadali Alizadeh iD, Jiayu Zheng, Charlotte Fletcher iD, Bhavya Gupta, Myles St-Denis, Nitish Boodhoo, Shayan Sharif

Viruses · 2024

DOI: 10.3390/v16071156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Fatemeh Fazel und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Chickens, Marek Disease, Marek Disease Vaccines, Cytokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada (NSERC), Ontario Agri-Food Innovation Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marek’s disease (MD), caused by the Marek’s disease virus, is a lymphoproliferative disease in chickens that can be controlled by vaccination. However, the current vaccines can limit tumor growth and death but not virus replication and transmission. The present study aimed to evaluate host responses following intramuscular injection of an mRNA vaccine encoding gB and pp38 proteins of the MDV within the first 36 h. The vaccine was injected in low and high doses using prime and prime-boost strategies. The expression of type I and II interferons (IFNs), a panel of interferon-stimulated genes, and two key antiviral cytokines, IL-1β and IL-2, were measured in spleen and lungs after vaccination. The transcriptional analysis of the above genes showed significant increases in the expression of MDA5, Myd88, IFN-α, IFN-β, IFN-γ, IRF7, OAS, Mx1, and IL-2 in both the spleen and lungs within the first 36 h of immunization. Secondary immunization increased expression of all the above genes in the lungs. In contrast, only IFN-γ, MDA5, MyD88, Mx1, and OAS showed significant upregulation in the spleen after the secondary immunization. This study shows that two doses of the MDV mRNA vaccine encoding gB and pp38 antigens activate innate and adaptive responses and induce an antiviral state in chickens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChickensMarek DiseaseMarek Disease VaccinesCytokinesHerpesvirus 2, GallidAnimalsLungSpleenPoultry DiseasesmRNA VaccinesVaccinationRNA, MessengerVaccines, Synthetic

Stichwörter der Autor:innen

Marek’s disease viruschickencytokinesimmune responsemRNA vaccine

Substanzen

Marek Disease VaccinesCytokinesmRNA VaccinesRNA, MessengerVaccines, Synthetic

Autor:innen und Institutionen

  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.

ORCID-Profile: Ayumi Matsuyama-Kato, Mohammadali Alizadeh, Charlotte Fletcher

Förderung

  • Natural Sciences and Engineering Research Council of Canada (NSERC)
  • Ontario Agri-Food Innovation Alliance

Zitieren

APA

Fazel, F., Matsuyama-Kato, A., Alizadeh, M., Zheng, J., Fletcher, C., Gupta, B., St-Denis, M., Boodhoo, N., & Sharif, S. (2024). A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens. Viruses. https://doi.org/10.3390/v16071156

Vancouver

Fazel F, Matsuyama-Kato A, Alizadeh M, Zheng J, Fletcher C, Gupta B, et al. A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens. Viruses. 2024. doi:10.3390/v16071156

BibTeX
@article{Fazel2024,
  author = {Fazel, Fatemeh and Matsuyama-Kato, Ayumi and Alizadeh, Mohammadali and Zheng, Jiayu and Fletcher, Charlotte and Gupta, Bhavya and St-Denis, Myles and Boodhoo, Nitish and Sharif, Shayan},
  title = {A Marek’s Disease Virus Messenger RNA-Based Vaccine Modulates Local and Systemic Immune Responses in Chickens},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16071156}
}
Kostenlos starten →